Trial Profile
A phase II Study of Carboplatin plus oral S1 in Chemo-Naive Patients with Squamous Cell Lung Cancer (OSAKA-LCSG1102)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jan 2020
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 04 Jan 2020 Status changed from active, no longer recruiting to completed.
- 30 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan (UMIN000005875).
- 01 Jul 2011 New trial record